thyroxine has been researched along with Hyperlipoproteinemias in 6 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Hyperlipoproteinemias: Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dobiásová, M | 1 |
Vondra, K | 1 |
Matousek, V | 1 |
Válek, J | 1 |
Weisweiler, P | 1 |
Schwandt, P | 1 |
Davignon, J | 1 |
Bogner, U | 1 |
Arntz, HR | 1 |
Peters, H | 1 |
Schleusener, H | 1 |
Glueck, CJ | 1 |
Lang, J | 1 |
Tracy, T | 1 |
Speirs, J | 1 |
Wallace, RB | 1 |
Pomrehn, P | 1 |
Heiss, G | 1 |
Chambless, LE | 1 |
Johnson, N | 1 |
Patten, R | 1 |
Lippel, K | 1 |
Rifkind, BM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT00005128] | 0 participants | Observational | 1972-07-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for thyroxine and Hyperlipoproteinemias
Article | Year |
---|---|
Prospects for drug therapy for hyperlipoproteinaemia.
Topics: Animals; Cholesterol; Forecasting; Humans; Hyperlipoproteinemias; Intestinal Absorption; Molecular S | 1995 |
5 other studies available for thyroxine and Hyperlipoproteinemias
Article | Year |
---|---|
Rate of LCAT-mediated cholesterol esterification and serum lipids during etiroxate therapy in hyperlipoproteinemia.
Topics: Body Weight; Cholesterol; Cholesterol Esters; Female; Humans; Hyperlipoproteinemias; Lipids; Lipopro | 1982 |
[Lipoproteins and hyperlipoproteinemias].
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperl | 1980 |
Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified.
Topics: Adolescent; Adult; Age Factors; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Human | 1993 |
The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinemia.
Topics: Adult; Aged; Cholesterol, LDL; Diagnosis, Differential; Evaluation Studies as Topic; Female; Humans; | 1991 |
Alterations in clinical chemistry levels associated with the dyslipoproteinemias. The Lipid Research Clinics Program Prevalence Study.
Topics: Adult; Blood Glucose; Creatinine; Diabetes Mellitus; Dysgammaglobulinemia; Female; Humans; Hyperlipo | 1986 |